NVCR
NovoCure Ltd. (NVCR)
NASDAQ · Healthcare
NovoCure Ltd. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- NovoCure Ltd. revenue for the quarter ending March 31, 2026 was 174.1 M, a 12.30% increase year-over-year.
- NovoCure Ltd. revenue for the twelve months ending March 31, 2026 was 655.1 M, a 14.67% increase year-over-year.
- NovoCure Ltd. annual revenue for 2025 was 655.4 M, a 8.28% increase from 2024.
- NovoCure Ltd. annual revenue for 2024 was 605.2 M, a 18.82% increase from 2023.
- NovoCure Ltd. annual revenue for 2023 was 509.3 M, a 5.30% decrease from 2022.
- NovoCure Ltd. annual revenue for 2022 was 537.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NovoCure Ltd. Market Cap — FAQ
NovoCure Ltd. (NVCR) market cap over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVCR's market cap history?
The chart and table above show NovoCure Ltd.'s market cap by year and by quarter, including the growth rate.